New York, October 30, 2021 –The global endometriosis market is expected to reach USD 2544.2 Million in 2028 and register a steady revenue CAGR of 2.6% over the forecast period, according to latest report published by Reports and Data. Key factors driving global market revenue growth are rising prevalence of endometriosis, increasing female population of the reproductive age group across the globe, and rising focus on improving women’s health.
Increasing awareness about diagnosis of endometriosis, availability of effective treatment, and increasing investments in research and development in the field are key factors driving global market revenue growth
Download PDF Sample Copy @ https://www.reportsanddata.com/sample-enquiry-form/2553
Endometriosis is a common chronic gynecological condition that affects nearly 11% of females in age group of 15 – 44 years globally. It is a progressive disease, in which a lining begins to grow on the outside of the uterus leading to severe problems such as chronic pelvic pain, painful periods, excessive bleeding, and pain during sexual activities. This condition drastically affects women’s reproductive functions along with quality of life. Though there is no permanent cure for this condition till now, various treatments, surgeries, and hormonal therapies are widely used to reduce or eliminate the pain caused during endometriosis. Revenue growth of the global market is significantly driven by factors such as increasing research activities for developing new drugs and treatment, government initiatives and programs on women’s health, and rising demand for high-cost hormone-based therapeutics. In addition, various major players are focusing on developing cost-effective drugs and therapeutically enhanced treatment for endometriosis.
However, unavailability of non-invasive diagnostic techniques, lack of skilled healthcare professionals in various developing countries, and possible side effects of certain medications including hot flashes, vaginal dryness, joint, and muscle stiffness are some key factors that could hamper market revenue growth to a certain extent over the forecast period.
To know more about the report @ https://www.reportsanddata.com/report-detail/endometriosis-market
Some key highlights of the report:
- Based on diagnosis, the laparoscopy segment is expected to account for significantly large revenue share during the forecast period. Factors such as increasing global cases of endometriosis, rising number of females of reproductive age group, availability of advanced laparoscopic procedures, and improving healthcare infrastructure and facilities are factors driving revenue growth of the segment.
- Base on drug type, the Gonadotropins Releasing Hormone (GnRH) agonists segment is expected to account for considerably large revenue share between 2021 and 2028 owing to high usage of GnRH analogues as a second-line therapy to minimize recurrence of endometriosis after surgery.
- Based on treatment, the hormonal therapy segment is expected to register for fastest revenue growth over the forecast period owing to increasing prevalence of endometriosis, rising demand for high-cost hormone based therapies, easy availability of hormonal drugs, and increasing investments to develop advanced products.
- Among the end use, the drugstore segment is expected to account for largest revenue share over the forecast period owing to rising prevalence of the condition across the globe, and high demand for various over-the-counter medicines and prescription drugs for hormonal therapies.
- The market in Europe is expected to account for a considerably large revenue share during the forecast period owing to high endometriosis patient pool, increasing awareness among people about health issues, increasing healthcare spending, and availability of advanced diagnosis and treatment.
- Revenue from the Asia Pacific market is expected to expand at highest growth rate between 2021 and 2028 owing to factors such as increasing prevalence of the condition, rising number of women under reproductive age group, and increasing investments by public and private sectors to increase public awareness about women health. In addition, increasing healthcare spending, and ongoing research on developing novel drugs and treatments are factors expected to drive revenue growth of the market in Asia Pacific going ahead.
- AbbVie Inc., AstraZeneca Plc., Bayer HealthCare Pharmaceuticals, Debiopharm International SA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Meditrina Pharmaceuticals Inc., Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories, Neurocrine Biosciences, Inc., Astellas Pharma Inc., Evotec AG, Addex Therapeutics, Kissei Pharmaceutical Co., Ltd., ElexoPharm, EndoCeutics, Gedeon Richter Plc., Myovant Sciences, Mayne Pharma Group Ltd., and Merck and Co. Inc. are some of the key players operating in the global market.
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2553
For the purpose of this report, Reports and Data has segmented the global endometriosis market based on diagnosis, drug type, treatment, end use, and region:
Diagnosis Outlook (Revenue, USD Million; 2018-2028)
- Ultrasound
- Pelvic Exam
- Laparoscopy
- Magnetic Resonance Imaging (MRI)
- Hysteroscopy
- Sonohysterography
Drug Type Outlook (Revenue, USD Million; 2018-2028)
- NSAIDs
- Gonadotropins Releasing Hormone Agonists
- Progestin
- Oral Contraceptive Pills
Treatment Outlook (Revenue, USD Million; 2018-2028)
- Hormonal Therapy
- Pain Management
End Use Outlook (Revenue, USD Million; 2018-2028)
- Hospital
- Pharmacies
- Drugstores
- E-commerce
Buy Now Premium Research Report – https://www.reportsanddata.com/checkout-form/2553
Regional Outlook (Revenue, USD Million, 2018-2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Sweden
- Benelux
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Rest of MEA
Similar Research reports by Reports and Data of Pharma and Healthcare Industry:
Allergy Immunotherapy Market Share & Trends Analysis Report by Type of Immunotherapy (Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT), Others), by Allergy Type (Allergic Rhinitis, Asthma, Food, Others), by Region, Competitive Strategies and Segment Forecasts, 2020-2028
Sterilization Equipment Market Analysis, By Product and Service (Sterilization Instrument, Sterilization Services, Sterilization Consumables and Accessories), End-User (Pharmaceutical Companies, Hospitals, Medical Device Companies), Forecasts to 2028
Nanomedicine Market Analysis By Products (Therapeutics, Regenerative Medicine, In-vitro diagnostics, In-vivo diagnostic, Vaccines), By Drug Delivery System (Nanobots, Nanoghosts, Nanoclusters, Nanobubbles, Exosomes, Injectable Nanoparticle Generator, Dendrimers, Liposomes, Carbon nanotube, Graphene, Others), By Application (Oncology, Infectious diseases, Cardiology, Orthopedics, Others) And Segment Forecasts to 2028
Dystrophin Market Analysis By Product (Exondys51, Translarna, Emflaza) by Approach (Exon Skipping, Anti-Inflammatory Therapy, Stop Codon Read-Through) and Segment Forecasts to 2026
About Reports and Data:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read Latest Press Release @ https://www.reportsanddata.com/press-release/global-endometriosis-market